Not logged in.png)
Share.png)
SaveShare Save Citron kinase is a novel driver of prostate cancer progression and controls alternative splicing associated with treatment-resistance
Rawat, Chitra; Singh, Nidhi; Chauhan, Gaurav; Rabljenovic, Anja; Ben-Salem, Salma; Vaghela, Vishwa; Venkadakrishnan, Varadha B.; MacDonald, Jonathan; Dahiya, Ujjwal; DePriest, Adam D.; Lee, Sanghee; Muldong, Michelle; Kim, Hyun-Tae; Kumari, Sangeeta; Hu, Qiang; Cortes, Eduardo; Dehm, Scott M.; Zoubeidi, Amina; Jamieson, Christina A. M.; Nicolas, Marlo; McKenney, Jesse; Willard, Belinda; Klein, Eric A.; Magi-Galluzzi, Cristina; Stauffer, Shaun R.; Liu, Song; Heemers, Hannelore V. Share Save A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximabLee, Sang-Kyu; Cho, Yong-Hee; Cha, Pu-Hyeon; Yoon, Jeong-Soo; Ro, Eun Ji; Jeong, Woo-Jeong; Park, Jieun; Kim, Hyuntae; Kim, Tae Il; Min, Do Sik; Han, Gyoonhee; Choi, Kang-Yell Share Save Share Save Share Save Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein StabilizationYang, Jee Sun; Lee, Chulho; Cho, Misun; Kim, Hyuntae; Kian, Jae Hyun; Choi, Seonghwi; Oh, Soo Jin; Kang, Jong Soon; Jeong, Jin-Hyun; Kim, Hyun-Jung; Han, Gyoonhee Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
